Prostate-specific antigen levels and density in the internal and external glands of the prostate in benign prostatic hyperplasia patients with normal or gray-zone PSA levels

Urologia Internationalis

Volumn 71, Issue 2, 2003, Pages 154-159

  Zuo, Wei ^a   Hiraoka, Yasunori ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Benign prostatic hyperplasia; External gland; Internal gland; Prostate; Prostate specific antigen

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CALCULATION; CONTROLLED STUDY; DENSITY; ENUCLEATION; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE SECRETION; SURGICAL PATIENT; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION;

AGED; CASE-CONTROL STUDIES; HUMANS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE;

EID: 0042674029     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071838     Document Type: Article

References (22)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM: Purification of a human prostate-specific antigen. Invest Urol 1979;25:159-163.
2. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;127:1156-1161.
3. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH: Prostate specific antigen density: A means of distinguishing between prostatic hypertrophy and prostate cancer. J Urol 1992;147:815-816.
4. Zlotta AR, Djavan B, Marberger M, Schulman CC: Prostate specific antigen density of the transition zone: A new effective parameter for prostate cancer. J Urol 1997;157:1315-1321.
5. Djavan B, Zlotta AR, Byttebier G, Shariat S, Omar M, Schulman CC, Marberger M: Prostate-specific antigen density of the transition zone for early detection of prostate cancer. J Urol 1998;160:411-418.
6. Hiraoka Y, Akimoto M: Transurethral enucleation of benign prostatic hyperplasia. J Urol 1989;142:1247-1250.
7. Terris MK, Stamey TA: Determination of prostate volume by transrectal ultrasound. J Urol 1991;145:984-987.
8. Oesterling JE: Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907-923.
9. Kuriyama M: Prostate-specific antigen as a tumor marker in prostate cancer. Int J Urol 1994; 1:99-113.
10. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, Kernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, Waters WB, MacFarlane MT, Southwick PC: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. J Urol 1994;151: 1283-1290.
11. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-916.
12. Seaman E, Whang M, Olsson CA, Katz A, Cooner WH, Benson MC: PSA density (PSAD). Role in patient evaluation and management. Urol Clin North Am 1993;20:653-663.
13. Benson MC, Whang IS, Olsson CA, McMahon DJ, Cooner WH: The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen. J Urol 1992;147:817-821.
14. Rommel FM, Augusta VE, Breslin JR, Huffnagle HW, Pohl CE, Sieber PR, Stahl CA: The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice. J Urol 1994;151:88-93.
15. Bazinet M, Meshref AW, Trudel C, Aronson S, Peloquin F, Nachabe M, Begin LR, Elhilali MM: Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma. Urology 1994;43:44-51.
16. Brawer MK, Aramburu EAG, Chen GL, Preston SD, Ellis WJ: The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma. J Urol 1993;150:369-373.
17. Cookson MS, Floyd MK, Ball TP Jr, Miller EK, Sarosdy MF: The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels. J Urol 1995;154:1070-1073.
18. Kalish J, Cooner WH, Graham SD: Serum PSA adjusted volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate. Urology 1994;43: 601-606.
19. Hammerer PG, McNeal JE, Stamey TA: Correlation between serum prostate specific antigen levels and the volume of the individual glandular prostate volumes of human prostate. J Urol 1995;153:111-114.
20. Kurita Y, Ushiyama T, Suzuki K, Fujita K, Kawabe K: PSA value adjusted for the transition zone volume in the diagnosis of prostate cancer. Int J Urol 1996;3:367-372.
21. Lepor H, Wang B, Shapio E: Relationship between prostatic epithelial volume and serum prostate-specific antigen levels. Urology 1994;44:199-205.
22. Aus G, Bergdahl S, Huggosson J, Norlen L: Volume determinations of the whole prostate and of adenomas by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: Correlation of resected weight, blood loss and duration of operation. Br J Urol 1994;73:659-663.